Preventive therapy for breast cancer with different agents such as selective estrogen receptor modulators and aromatase inhibitors has been shown to reduce the risk of breast cancer by 49% and 65%, respectively (2, 3). This evidence concerns the gene ESR1 and breast carcinoma.